Chennai: Public Health Foundation of India (PHFI) and Dr. Mohan's Diabetes Education Academy (DMDEA) announced the launch and expansion of CCEBDM (Certificate Course in Evidence Based Diabetes Management) to develop core skills and competencies in primary care physicians for the practice of evidence based diabetes management, focused on the management of Type 2 Diabetes.
An educational grant for this capacity building initiative has been provided by MSD Pharmaceuticals Pvt. Ltd. (MSD India), a wholly owned subsidiary of Merck & Co., Inc., Whitehouse Station, New Jersey, USA.
Type 2 Diabetes (T2DM), has become a serious health threat with exploding population and changing lifestyle. The prevalence of type 2 diabetes has achieved an endemic proportion and is currently a global public health threat. The prevalence of T2DM among adults is expected to rise from 285 million in 2010 to 438 million by the year 20301. The numbers would probably be even far more disturbing if we count the number of associated lifestyle disorders like obesity, hypertension, dyslipidemia and impaired glucose tolerance.
Diabetes is a considerable cause of premature mortality, a situation that is likely to worsen, particularly in low and middle income countries as diabetes prevalence increases. Surveys suggest that in the urban areas of the country almost 11 per cent of the population suffer from diabetes2. The ICMR-INDIAB study3 published last year projected that in 2011, 62.4 million and 77.2 million people in India were living with diabetes and pre-diabetes respectively.
The aim of the program, CCEBDM, is to impart on-job training to the primary care physicians on the latest advances in the field of Diabetes Management. The course curriculum is divided into twelve modules spread over 12 months under which physicians are trained by regional faculty identified by the program organizers.
No comments:
Post a Comment